Prospective Study of Rapamycin for the Treatment of SLE

NCT00779194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: Rapamycin

Sponsor

State University of New York - Upstate Medical University

Collaborators

[object Object]